Jennifer Allison Haworth Sells 10,000 Shares of Globe Life (NYSE:GL) Stock

Globe Life Inc. (NYSE:GL) CMO Jennifer Allison Haworth sold 10,000 shares of the firm’s stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $143.14, for a total value of $1,431,400.00. Following the completion of the sale, the chief marketing officer directly owned 17,479 shares of the company’s stock, valued at approximately $2,501,944.06. This represents a 36.39% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link.

Globe Life Stock Performance

Shares of Globe Life stock opened at $144.46 on Friday. The company has a 50 day moving average price of $140.57 and a 200 day moving average price of $138.41. The firm has a market capitalization of $11.50 billion, a P/E ratio of 10.26 and a beta of 0.47. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.41. Globe Life Inc. has a 52 week low of $109.38 and a 52 week high of $152.71.

Globe Life (NYSE:GL) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The company had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same quarter in the previous year, the company posted $3.14 EPS. The company’s revenue for the quarter was up 3.6% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Sell-side analysts expect that Globe Life Inc. will post 13.87 EPS for the current year.

Analyst Ratings Changes

Several research analysts have recently issued reports on the company. Morgan Stanley restated an “overweight” rating and issued a $176.00 price objective on shares of Globe Life in a research note on Monday, December 15th. JPMorgan Chase & Co. raised their price target on shares of Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Weiss Ratings raised shares of Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a report on Friday. Evercore lowered shares of Globe Life from an “outperform” rating to an “in-line” rating and set a $155.00 price objective on the stock. in a research note on Tuesday, January 6th. Finally, Wells Fargo & Company reduced their target price on shares of Globe Life from $172.00 to $170.00 and set an “overweight” rating for the company in a report on Friday, October 24th. Eight equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $171.00.

Hedge Funds Weigh In On Globe Life

Several large investors have recently made changes to their positions in the company. Mather Group LLC. purchased a new position in Globe Life in the third quarter valued at $28,000. Hilton Head Capital Partners LLC purchased a new stake in shares of Globe Life during the 4th quarter worth about $30,000. CYBER HORNET ETFs LLC acquired a new stake in shares of Globe Life during the 2nd quarter valued at about $28,000. Assetmark Inc. increased its stake in shares of Globe Life by 777.8% in the 2nd quarter. Assetmark Inc. now owns 237 shares of the company’s stock valued at $29,000 after purchasing an additional 210 shares in the last quarter. Finally, MUFG Securities EMEA plc acquired a new position in Globe Life in the 2nd quarter worth about $31,000. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.